IndiGo Cancels 800+ Flights; Govt Caps Fares, Orders Refunds

A day after successfully securing significant relaxations in the second phase of the court-mandated revised flight duty and rest time rules for the cockpit crew, IndiGo canceled more than 400 flights from four major airports on Saturday, December 6, 2025, according to sources. These included 109 flights (51 departures and 58 arrivals) at Mumbai airport … Read more

IndiGo Cancels 800 Flights, Prioritizes Refunds

IndiGo, a domestic airline, said that it canceled more than 800 flights on Saturday—much less than the over 1,000 on Friday—and that it is giving all consumer refund concerns “priority.” After informing the aviation safety regulator that it was facing major transitional challenges in roster planning and crew availability under Phase-2 FDTL requirements, the airline … Read more

Air India Caps Budget Fares Amid IndiGo Travel Chaos

Air India and Air India Express said on Saturday that they have been proactively restricting economy-class tickets on all non-stop domestic flights since December 4, despite the fact that IndiGo’s extensive operational delays continue to cause discomfort to thousands of travelers. According to the airlines, the action is intended to stop dynamic pricing algorithms amid … Read more

Govt Clamps Down on Airfare Surge Amid IndiGo Chaos

Due to the inconveniences caused by the continuing IndiGo crisis, airplane ticket costs have skyrocketed to unbelievable heights. The Center has instructed all airlines to carefully adhere to the newly recommended rate ceilings. The Civil Aviation Ministry’s directive, which sought to shield travelers against “opportunistic pricing,” issued a warning that any increase in fares above … Read more

Biocon Merges Biocon Biologics, Plans ₹4,500 Cr QIP

With an anticipated completion date of March 31, 2026, the biopharma giant Biocon has merged Biocon Biologics Limited (BBL), a wholly-owned subsidiary, with Biocon Limited. In order to store all biosimilar assets and eventually unlock value, Biocon Biologics was established in 2017 as a distinct subsidiary. The worldwide biosimilars division of Viatris was purchased by … Read more